Grüezi! Sie wurden auf, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'470 1.7%  SPI 13'410 1.7%  Dow 29'491 2.7%  DAX 12'511 2.5%  Euro 0.9747 0.0%  EStoxx50 3'437 2.8%  Gold 1'706 0.4%  Bitcoin 19'688 1.1%  Dollar 0.9888 -0.4%  Öl 89.6 1.1% 

News + Analysen
News + Adhoc
zugeh. Wertpapiere
Strukturierte Produkte
11.08.2022 21:18:17

Why Wave Life Sciences Was Zooming Higher Today

There was a great deal of life in Wave Life Sciences (NASDAQ: WVE) stock on Thursday. As of midafternoon trading, investors had bid the company's share price up by more than 25%, comparing very favorably to the marginal gain eked out by the S&P 500 index. That was due almost entirely to the clinical-stage biotech's latest set of quarterly results and business update. Before market open, Wave published its second-quarter results. These showed that, although the company is mostly pre-revenue at this stage of its existence, it nevertheless booked $375,000 on the top line. This was down from the nearly $2.8 million it earned in the same quarter last year.Somewhat predictably net loss deepened, but not by a significant amount. It came in at slightly more than $41 million ($0.62 per share), against the year-ago deficit of almost $39 million.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"


Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.